A meta-analysis has reported an association between statin and increased fatality in studies restricted to tPA-treated patients20, which together with the increased rates of intracerebral hemorrhage in SPARCL trial (Stroke Prevention by Aggressive Reduction in Cholesterol Levels)21. The gene discussed is PLAT; the disease is intracerebral hemorrhage.